Get the Stockscreener App
0.00
100.00%
-0.034
Accelerate Diagnostics Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Accelerate Diagnostics Inc is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Its Clinical Microbiology products include Accelerate Pheno system, Accelerate PhenoTest BC Kit, and Accelerate Arc module & BC kit. The company earns the majority of its revenue from the domestic market. The group operates as one operating segment, deriving instrument, consumable, and service revenues from customers engaged in healthcare diagnostics within the United States. Product revenue is derived from the sale or rental of instruments and sales of related consumable products. Service revenue is derived from the sale of extended service agreements.
See More
Previous Close:
$0.034
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$3.74M
Revenue:
$12.00M
Net Income/Loss:
$-63.23M
P/E Ratio:
0.00
EPS:
-6
Net Cash Flow:
$-43.02M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$2.09
Accelerate Diagnostics Inc Stock (AXDX) Company Profile
Name
Accelerate Diagnostics Inc
Sector
Industry
Phone
303-863-8088
Address
3950 S. COUNTRY CLUB ROAD #470, TUCSON, AZ
Compare AXDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AXDX
Accelerate Diagnostics Inc
|
0.00 | 3.74M | 12.00M | -63.23M | -43.02M | -6.00 |
|
ABT
Abbott Laboratories
|
125.23 | 229.71B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.78 | 154.35B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
390.78 | 149.60B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.36 | 114.97B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.43 | 45.92B | 5.54B | 4.18B | 623.10M | 7.00 |
Accelerate Diagnostics Inc Stock (AXDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-09-22 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-08-20 | Initiated | BTIG Research | Neutral |
| Aug-07-20 | Upgrade | Craig Hallum | Hold → Buy |
| Sep-27-19 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-07-18 | Downgrade | JP Morgan | Overweight → Neutral |
| May-24-18 | Initiated | Craig Hallum | Hold |
| Dec-13-17 | Downgrade | BTIG Research | Buy → Neutral |
| Jul-12-17 | Resumed | BTIG Research | Buy |
| Mar-24-16 | Initiated | JP Morgan | Overweight |
| Dec-16-15 | Initiated | Piper Jaffray | Overweight |
View All
Accelerate Diagnostics Inc Stock (AXDX) Latest News
What analysts say about Accelerate Diagnostics Inc. stockLightning-fast growth - Autocar Professional
Will Accelerate Diagnostics Inc. stock benefit from interest rate changesInsider Level Guidance - beatles.ru
Is Accelerate Diagnostics Inc. a good long term investmentRapid-fire capital growth - Autocar Professional
What drives Accelerate Diagnostics Inc. stock priceExplosive market performance - jammulinksnews.com
How Bleichroeder Acquisition Corp. I Equity Right stock performs during market volatilityFree Short-Term Stock Picks - Newser
Why Accelerate Diagnostics Inc. stock attracts strong analyst attentionLow Risk Entry Points - Newser
How Accelerate Diagnostics Inc. stock performs during market volatilitySafety First Trading Signals - Newser
What makes Accelerate Diagnostics Inc. stock price move sharplyFree Exclusive Stock Market Insights - Newser
Summit Partners Announces Growth Investment in Dreampath Diagnostics to Accelerate Digital Transformation in Anatomical Pathology - Business Wire
Accelerate Diagnostics faces Nasdaq delisting risk - MSN
Unexpected Trends Reshaping the Antimicrobial Susceptibility - openPR.com
Firm Retention Summary: Accelerate Diagnostics - The Wall Street Journal
Company earnings calendar - Yahoo
Court approves stalking horse bidder in Accelerate Diagnostics bankruptcy sale - The Business Journals
Med Tech Co. Accelerate Diagnostics Can Tap $20M DIP Loan - Law360
ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform - The Manila Times
ProPhase Labs Announces Formation of Clinical Science - GlobeNewswire
Bidding Procedure Approved for Accelerate Diagnostics, Inc. - marketscreener.com
Accelerate Diagnostics Files for Chapter 11 Bankruptcy - TipRanks
QuidelOrtho Makes Major Molecular Diagnostics Pivot: $100M LEX Acquisition to Replace Savanna Platform - Stock Titan
TriSalus Life Sciences Announces Chief Financial Officer Transition With Appointment of David B. Patience - Business Wire
Accelerate Diagnostics CFO Resignation Announced - TipRanks
Roche announces new collaboration with Broad Clinical Labs to accelerate adoption of cutting-edge SBX sequencing technology - Roche
Healthcare Spending Slowdown Sparked Accelerate's Ch. 11 - Law360
Accelerate Diagnostics (NASDAQ:AXDX) Coverage Initiated at StockNews.com - Defense World
Life-saving healthcare company files for Chapter 11 bankruptcy - MSN
Major health care company files for bankruptcy to sell assets - TheStreet
Accelerate Diagnostics Delays 10-Q Filing Amid Bankruptcy - TipRanks
Accelerate Diagnostics (AXDX) Options Delisted Effective May 15t - GuruFocus
Nasdaq Gains Over 100 Points; Sony Group Posts Upbeat Earnings - Benzinga
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.21% - Investing.com
Catching Up With New Bankruptcy Case Action - Law360
Why Coinbase Global Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket - Benzinga
StockNews.com Begins Coverage on Accelerate Diagnostics (NASDAQ:AXDX) - Defense World
Accelerate Diagnostics: A Contrarian’s Play in the Rapid Diagnostics Revolution - AInvest
Accelerate Diagnostics, Inc.(NasdaqCM: AXDX) dropped from S&P TMI Index - marketscreener.com
Accelerate Diagnostics files for Chapter 11 bankruptcy, seeks asset sale amid financial strain - ABC15 Arizona
Accelerate Diagnostics (AXDX) to Release Earnings on Wednesday - Defense World
Arizona-Based Accelerate Diagnostics Files for Bankruptcy, Plans Asset Sale - NewsBreak: Local News & Alerts
Accelerate Diagnostics Inc Stock (AXDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.95%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):